大麻医薬品の世界市場2020-2027:ブランド別(Epidiolex、Sativex)、地域別

◆英語タイトル:Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report By Brand (Epidiolex, Sativex), By Region (North America, Europe, Asia Pacific, Latin America & MEA), And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN028
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年5月
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、大麻医薬品の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、ブランド別(Epidiolex、Sativex)分析、地域別分析、競争状況など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・大麻医薬品の世界市場規模:ブランド別(Epidiolex、Sativex)
・大麻医薬品の世界市場規模:地域別
・競争状況
【レポートの概要】

Cannabis Pharmaceuticals Market Growth & Trends

The global cannabis pharmaceuticals market size is projected to reach USD 5.8 billion by 2027, expanding at a CAGR of 76.8% over the forecast period, according to a new report by Grand View Research, Inc. Rise in the number of clinical trials for these drugs due to its therapeutic properties, growing awareness of the medical benefits of plant-derived cannabidiol products are some of the factors driving the demand over the forecast period. However, the presence of stringent regulations on cannabidiol-infused products in various countries is restricting demand for these products.

In 2019, Sativex is the leading brand in the global market with a revenue share of 83.0%. The surge in clinical trials for numerous medical conditions and the growing number of countries legalizing cannabis for medical purposes are the major factors responsible for its large share. On the other hand, Epidiolex is anticipated to be the fastest-growing brand over the forecast period. Growing research for plant-based cannabinoids for other rare conditions is expected to drive the growth of this segment over the forecast period.

The European region is expected to dominate the market in 2019, owing to growing medical marijuana users in the region coupled with the rising awareness about cannabidiol infused products. On the other hand, the Asia Pacific region is expected to grow at the fastest rate over the forecast period owing to growing legalization and favorable guidelines towards the use of cannabidiol infused pharma products in the region.

Cannabis Pharmaceuticals Market Report Highlights

• In 2019, Sativex is estimated to dominate the market with a revenue share of 83.0%, due to the growing number of countries legalization of plant-derived pharma products for medical purpose

• In terms of revenue, U.S. was the largest country level market. U.S.FDA’s approval of Epidiolox and high adoption of this drug are few factors for the country’s large share.

• Some of the major players operating in this cannabis pharmaceuticals market are GW Pharmaceuticals, AbbVie Inc., Valeant Pharmaceuticals, and Insys Therapeutics, Inc.

【レポートの目次】

Table Of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.3.1 Region Market: CAGR Calculation
1.4 Region Based Segment Share Calculation
1.5 List of Secondary Sources
1.6 List of Primary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Cannabis Pharmaceuticals Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & Growth Prospects Mapping
3.4 Global Cannabis Pharmaceuticals Regulatory Scenario
3.5 Cannabis Pharmaceuticals – PESTEL Analysis
3.5.1. Political
3.5.2. Environmental
3.5.3 Social
3.5.4 Technology
3.5.5. Legal
3.5.6 Economic
3.6 Cannabis Pharmaceuticals – Porter’s Analysis
3.6.1. Threat of New Entrants
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Bargaining Power of Suppliers
3.6. 5 Threat of Substitutes
3.7 Opportunity Analysis (2016 – 2019-2027)
3.8 Product Pipeline Analysis, By Stage
3.9 Key Deals and Strategic Aliances
3.10 Synthetic Cannabis Pharmaceuticals Overview
Chapter 4 Cannabis Pharmaceuticals Market: Brand Estimates & Trend Analysis
4.1 Cannabis Pharmaceuticals Market Size & Forecasts And Trend Analysis By Brand, 2016 – 2027, (USD Million)
4.1.1 Sativex
4.1.1.1 Sativex Market Estimates and Forecasts, 2016 – 2027 (USD Million)
4.1.2 Epidiolex
4.1.2.1 Epidiolex Market Estimates and Forecasts, 2016 – 2027 (USD Million)
Chapter 5 Cannabis Pharmaceuticals Market: Regional Estimates & Trend Analysis
5.1 Global Cannabis Pharmaceuticals Market Share, By Country, 2019 & 2027
5.1.1 North America
5.1.1.1 North America Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.1.2 U.S.
5.1.1.2.1 U.S. Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.1.3 Canada
5.1.1.3.1 Canada Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2 Europe
5.1.2.1 Europe Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.2 U.K.
5.1.2.2.1 U.K. Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.3 Germany
5.1.2.3.1 Germany Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.4 Italy
5.1.2.4.1 Italy Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.5 France
5.1.2.5.1 France Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.6 Netherlands
5.1.2.6.1 Netherlands Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.7 Poland
5.1.2.7.1 Poland Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.8 Croatia
5.1.2.8.1 Croatia Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.9 Czech Republic
5.1.2.9.1 Czech Republic Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.2.10 Switzerland
5.1.2.10.1 Switzerland Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.3 Asia Pacific
5.1.3.1 Asia Pacific Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.3.2 Japan
5.1.3.2.1 Japan Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.3.3 South Korea
5.1.3.3.1 South Korea Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.3.4 Australia
5.1.3.4.1 Australia Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.3.5 New Zealand
5.1.3.5.1 New Zealand Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.4 Latin America
5.1.4.1 Latin America Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.4.2 Brazil
5.1.4.2.1 Brazil Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.4.3 Mexico
5.1.4.3.1 Mexico Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.4.4 Argentina
5.1.4.4.1 Argentina Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.4.5 Colombia
5.1.4.5.1 Colombia Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.4.6 Uruguay
5.1.4.6.1 Uruguay Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.4.7 Chile
5.1.4.7.1 Chile Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.5 Middle East & Africa
5.1.5.1 Middle East & Africa Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
5.1.5.2 Israel
5.1.5.2.1 Israel Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 – 2027 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 GW Pharmaceuticals
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Product Offerings
6.1.1.4 Strategic Initiatives
6.1.2 AbbVie Inc.
6.1.2.1 Company Overview
9.1.2.2 Financial Performance
6.1.2.3 Product Offerings
6.1.2.4 Strategic Initiatives
6.1.3 Valeant Pharmaceuticals
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Product Offerings
6.1.3.4 Strategic Initiatives
6.1.4 Insys Therapeutics, Inc.
6.1.4.1 Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Product Offerings
6.1.4.4 Strategic Initiatives
6.2 List of Key Emerging Players
6.3 Company Categorization
6.4 Company Market Position Analysis
6.5 Company Market Share Analysis, 2019
6.6 Market Differentiators

List of Tables

Table 1 List of secondary sources
Table 2 List of primary sources
Table 3 North America Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 4 North America Cannabis Pharmaceuticals market, by sales channel, 2016 - 2027 (USD Million)
Table 5 U.S. Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 6 Canada Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 7 Europe Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 8 U.K. Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 9 Germany Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 10 France Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 11 Italy Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 12 Croatia Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 13 Netherlands Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 14 Poland Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 15 Switzerland Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 16 Czech Republic Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 17 Switzerland Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 18 Asia Pacific Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 19 Japan Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 20 South Korea Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 21 Australia Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 22 New Zealand Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 23 Brazil Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 24 Mexico Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 25 Argentina Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 26 Colombia Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 27 Uruguay Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 28 Chile Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
Table 29 Israel Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[大麻医薬品の世界市場2020-2027:ブランド別(Epidiolex、Sativex)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆